RFA-CD-18-000
Open
Centers for Disease Control and Prevention - ERA is offering grants to the applicants described in the notice. It expects to make about 100 awards. Applications close on September 30, 2030.
From the official notice on Grants.gov, last changed November 25, 2025. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awards100
- Total fundingnot stated
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | October 20, 2023 |
|---|---|
| Deadline | September 30, 2030 |
| Archived by Grants.gov | October 30, 2030 |
Add the deadline to your calendar
Who can apply
This opportunity is open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
States, Universities, County, Small Business, Non-Profits Organization,
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
Submit application as necessary for Type 6 Applications.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Linton C Browning, Grants Management Specialist, lbrowning@cdc.gov, 770-488-2756.
Questions people ask
Who can apply for RFA-CD-18-000?
Centers for Disease Control and Prevention - ERA accepts applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for RFA-CD-18-000?
Closes September 30, 2030 (1430 days left). Confirm the date and time in the official notice on Grants.gov.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience